Jefferies Upgrades Allscripts Healthcare To Buy

Analysts at Jefferies upgraded Allscripts Healthcare Solutions

from Hold to Buy. The target price for Allscripts Healthcare has been raised from $15 to $21. Allscripts Healthcare shares have surged 5.40% over the past 52 weeks, while the S&P 500 index has gained 17.20% in the same period. Allscripts Healthcare's shares fell 0.39% to close at $16.59 yesterday.